Theresia M. Westers

4.0k citations

90 papers · 1.6k indexed · h-index 23

Co-authors: Arjan A. van de Loosdrecht Gert J. Ossenkoppele Canan Alhan Hetty J. Bontkes Tanja D. de Gruijl Vincent H. J. van der Velden Ilse Houtenbos Martine E.D. Chamuleau
Topics: Acute Myeloid Leukemia Research (55 papers)Immunotherapy and Immune Responses (32 papers)Immune Cell Function and Interaction (26 papers)
Cited by: Hematology Genetics Immunology
Journals: Nature Communications Blood PLoS ONE
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Theresia M. Westers

81 papers receiving 1.5k citations

Peers

Countries citing papers authored by Theresia M. Westers

Since Specialization

Citations

This map shows the geographic impact of Theresia M. Westers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theresia M. Westers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theresia M. Westers more than expected).

Fields of papers citing papers by Theresia M. Westers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theresia M. Westers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theresia M. Westers. The network helps show where Theresia M. Westers may publish in the future.

Co-authorship network of co-authors of Theresia M. Westers

This figure shows the co-authorship network connecting the top 25 collaborators of Theresia M. Westers. A scholar is included among the top collaborators of Theresia M. Westers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theresia M. Westers. Theresia M. Westers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndrome 2025 ·Nature Communications ·(unknown),(unknown),(unknown),(unknown),(unknown),Remco M. Hoogenboezem,Eric M. Bindels,(unknown),Seyed Abolhassan Shahzadeh Fazeli,Aniek O. de Graaf,Theresia M. Westers,Maksim Kholmatov,Judith B. Zaugg,Pedro Luís Moura,Eva Hellström‐Lindberg,Arjan A. van de Loosdrecht,Joop H. Jansen,Mathijs A. Sanders,Marc H.G.P. Raaijmakers	0
2	The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells 2024 ·Cytometry Part B Clinical Cytometry ·(unknown),(unknown),Lok Lam Ngai,(unknown),(unknown),Willemijn J. Scholten,Angèle Kelder,Diana Hanekamp,(unknown),Noortje van Gils,Patrycja Gradowska,Bob Löwenberg,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht,Theresia M. Westers,Linda Smit,Costa Bachas,Jacqueline Cloos	3
3	Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells 2024 ·Leukemia ·(unknown),Sofie Van Gassen,Carolien Duetz,Theresia M. Westers,Yvan Saeys,Arjan A. van de Loosdrecht	3
4	Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression 2023 ·Leukemia ·(unknown),Diana Hanekamp,Theresia M. Westers,Noortje van Gils,(unknown),(unknown),Joop H. Jansen,Birgit I. Lissenberg‐Witte,Linda Smit,Gerrit Jan Schuurhuis,Arjan A. van de Loosdrecht	11
5	Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes 2018 ·Frontiers in Immunology ·(unknown),Kristina Lundberg,Theresia M. Westers,Shahram Kordasti,Hetty J. Bontkes,Malin Lindstedt,Tanja D. de Gruijl,Arjan A. van de Loosdrecht	15
6	Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias 2015 ·European Journal of Cancer ·Eline M.P. Cremers,Theresia M. Westers,Canan Alhan,Claudia Cali,Mariëlle J. Wondergem,Pino J. Poddighe,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht	24
7	Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen 2015 ·Cancer Immunology Immunotherapy ·Jurjen M. Ruben,Hetty J. Bontkes,Theresia M. Westers,Erik Hooijberg,Gert J. Ossenkoppele,Tanja D. de Gruijl,Arjan A. van de Loosdrecht	12
8	The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system 2015 ·Leukemia ·Canan Alhan,Theresia M. Westers,Eline M.P. Cremers,Claudia Cali,Birgit I. Lissenberg‐Witte,G.J. Ossenkoppele,Arjan A. van de Loosdrecht	27
9	A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation 2015 ·PLoS ONE ·Jurjen M. Ruben,Lindy L. Visser,Kimberley M. Heinhuis,Tom O’Toole,Hetty J. Bontkes,Theresia M. Westers,Gert J. Ossenkoppele,Tanja D. de Gruijl,Arjan A. van de Loosdrecht	3
10	Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines 2014 ·Cancer Immunology Immunotherapy ·Jurjen M. Ruben,Willemijn van den Ancker,Hetty J. Bontkes,Theresia M. Westers,Erik Hooijberg,Gert J. Ossenkoppele,Tanja D. de Gruijl,Arjan A. van de Loosdrecht	31
11	Immunophenotyping for diagnosis and prognosis in MDS: Ready for general application? 2014 ·Best Practice & Research Clinical Haematology ·Eline M.P. Cremers,Canan Alhan,Theresia M. Westers,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht	10
12	Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS 2014 ·Leukemia ·Anna Porwit,Arjan A. van de Loosdrecht,Peter Bettelheim,Lisa Eidenschink Brodersen,Kate Burbury,Eline M.P. Cremers,Matteo Giovanni Della Porta,Robin Ireland,Ulrika Johansson,Sergio Matarraz,Kíyoyuki Ogata,(unknown),Frank Preijers,Katherina Psarra,Dolores Subirá,Peter Valent,Vincent H. J. van der Velden,D. Wells,Theresia M. Westers,Wolfgang Kern,Marie C. Béné,(unknown)	90
13	MicroRNA Profiling Can Classify Acute Leukemias of Ambiguous Lineage as Either Acute Myeloid Leukemia or Acute Lymphoid Leukemia 2013 ·Clinical Cancer Research ·David C. de Leeuw,Willemijn van den Ancker,Fedor Denkers,Renée X. de Menezes,Theresia M. Westers,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht,Linda Smit	30
14	Cutting Edge: Flow Cytometry in Myelodysplastic Syndromes 2013 ·Journal of the National Comprehensive Cancer Network ·Arjan A. van de Loosdrecht,Theresia M. Westers	18
15	Azacitidine differentially affects CD4pos T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes 2012 ·Leukemia Research ·Hetty J. Bontkes,Jurjen M. Ruben,Canan Alhan,Theresia M. Westers,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht	34
16	Absence of Class II–Associated Invariant Chain Peptide on Leukemic Blasts of Patients Promotes Activation of Autologous Leukemia-Reactive CD4+ T Cells 2011 ·Cancer Research ·Marvin M. van Luijn,Willemijn van den Ancker,Martine E.D. Chamuleau,Adri Zevenbergen,Theresia M. Westers,Gert J. Ossenkoppele,S. Marieke van Ham,Arjan A. van de Loosdrecht	23
17	MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY 2011 ·Cytometry Part A ·Cristina Picone,(unknown),Laura Vanelli,Luca Malcovati,Cristiana Pascutto,Kíyoyuki Ogata,Hideto Tamura,(unknown),Magdalena Czader,Sylvie Freeman,Paresh Vyas,Anna Porwit,(unknown),Theresia M. Westers,Canan Alhan,Claudia Cali,Arjan A. van de Loosdrecht,Mario Cazzola,Matteo Giovanni Della Porta	1
18	Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome 2009 ·Haematologica ·Martine E.D. Chamuleau,Theresia M. Westers,(unknown),(unknown),Adri Zevenbergen,Corien Eeltink,G. J. Ossenkoppele,Arjan A. van de Loosdrecht	50
19	Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses 2009 ·Haematologica ·Marvin M. van Luijn,Martine E.D. Chamuleau,James A. Thompson,Suzanne Ostrand‐Rosenberg,Theresia M. Westers,Yuri Souwer,G.J. Ossenkoppele,S. Marieke van Ham,Arjan A. van de Loosdrecht	21
20	Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia 2003 ·Cancer Immunology Immunotherapy ·Theresia M. Westers,Anita G.M. Stam,Rik J. Scheper,(unknown),Aggie Nieuwint,G.J. Schuurhuis,Arjan A. van de Loosdrecht,Gert J. Ossenkoppele	49

About Theresia M. Westers

Theresia M. Westers is a scholar working on Hematology, Immunology and Genetics, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (55 papers), Immunotherapy and Immune Responses (32 papers) and Immune Cell Function and Interaction (26 papers). The work is most often cited by research in Hematology (996 citations), Genetics (396 citations) and Immunology (701 citations). Theresia M. Westers has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Arjan A. van de Loosdrecht, Gert J. Ossenkoppele, Canan Alhan, Hetty J. Bontkes, Tanja D. de Gruijl, Vincent H. J. van der Velden, Ilse Houtenbos, Martine E.D. Chamuleau, Angelika M. Dräger and August H. Westra. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact